EUVIMEDEUVIMED entdecken
Open Access

JMJD8 Regulates Adipocyte Hypertrophy Through the Interaction With Perilipin 2

Dongjoo You, Sona Kang iD

Diabetes · 2025

DOI: 10.2337/db23-0883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2025. Verfasst von Dongjoo You und 1 weiteren Autor:innen. Beteiligte Einrichtung: Nutritional Sciences and Toxicology Department, University of California, Berkeley, Berkeley, CA. Hauptthemen laut MEDLINE: Adipocytes, Perilipin-2, Jumonji Domain-Containing Histone Demethylases, Perilipins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Division of Diabetes, Endocrinology, and Metabolic Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adipocyte hypertrophy significantly contributes to insulin resistance and metabolic dysfunction. Our previous research established JMJD8 as a mediator of insulin resistance, noting its role in promoting adipocyte hypertrophy within an autonomous adipocyte context. Nevertheless, the precise mechanisms underlying this phenomenon remained elusive. In this study, we employed a proteomics approach to identify Perilipin 2 (PLIN2), a lipid-associated protein, as a binding partner of JMJD8. Our investigations unveils a robust interaction between JMJD8 and PLIN2, demonstrating its pivotal role in driving adipocyte hypertrophy and promoting insulin resistance. Furthermore, we show that JMJD8 suppresses fasting-induced lipophagy and curtails energy production, which involves inhibition of PLIN2 phosphorylation. These findings underscore the critical roles played by JMJD8 and PLIN2 in governing lipid droplet homeostasis, while also shedding light on a potential regulatory mechanism governing fat store mobilization during energy deprivation. Article Highlights New research builds on previous findings that JMJD8 mediates insulin resistance by promoting adipocyte hypertrophy. We identified PLIN2 as a binding partner of JMJD8 using proteomics approaches. This study reveals a physical interaction between JMJD8 and PLIN2, which plays a crucial role in driving adipocyte hypertrophy and insulin resistance. JMJD8 suppresses fasting-induced lipophagy and reduces energy production by inhibiting PLIN2 phosphorylation. These findings highlight the importance of JMJD8 and PLIN2 in regulating lipid droplet homeostasis and suggest a potential mechanism for controlling fat mobilization during energy deprivation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdipocytesPerilipin-2Jumonji Domain-Containing Histone DemethylasesPerilipinsAnimalsMiceHypertrophyInsulin ResistanceHumansPhosphorylation3T3-L1 Cells

Substanzen

Perilipin-2Jumonji Domain-Containing Histone DemethylasesPerilipinsPlin2 protein, mouse

Autor:innen und Institutionen

  • Nutritional Sciences and Toxicology Department, University of California, Berkeley, Berkeley, CA.

ORCID-Profile: Sona Kang

Förderung

  • NIDDK NIH HHS
  • Division of Diabetes, Endocrinology, and Metabolic Diseases

Zitieren

APA

You, D., & Kang, S. (2025). JMJD8 Regulates Adipocyte Hypertrophy Through the Interaction With Perilipin 2. Diabetes. https://doi.org/10.2337/db23-0883

Vancouver

You D, Kang S. JMJD8 Regulates Adipocyte Hypertrophy Through the Interaction With Perilipin 2. Diabetes. 2025. doi:10.2337/db23-0883

BibTeX
@article{You2025,
  author = {You, Dongjoo and Kang, Sona},
  title = {JMJD8 Regulates Adipocyte Hypertrophy Through the Interaction With Perilipin 2},
  journal = {Diabetes},
  year = {2025},
  doi = {10.2337/db23-0883}
}
Kostenlos starten →